BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience

GenEditBio Secures US FDA IND Clearance For First In Vivo Genome Editing Trial In TGFBI Corneal Dystrophy

GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, today announced that the U.S. F...

January 06, 2026 | News

26 Key Trends Shaping Biotech And Life Sciences In 2026

As 2026 unfolds, biotech and life sciences are moving into a phase defined less by promise and more by execution. Faster R and D cycles, smarter cl...

January 05, 2026 | News

How Asia Pacific Is Forcing A Rethink On Surgical Outcomes Measurement

As surgical volumes rise and care pathways grow more complex across Asia Pacific, the limitations of how post operative outcomes are measured are becoming ...

January 05, 2026 | Expert Insight | By editor@biopharmaapac.com

Nona Biosciences Expands Integrated Framework To Support Early Clinical Development And IITs

Nona Biosciences, a global biotechnology company advancing biotherapeutic discovery through innovative technology platforms, announced the expansion o...

January 02, 2026 | News

Sanofi To Acquire Dynavax For $15.50 Per Share In $2.2 Billion All Cash Deal

Dynavax stockholders to receive $15.50 in cash, a 39% premium to Dynavax closing share price onDecember 23, 2025 Sanofi announced that it has entered into...

January 02, 2026 | News

Harbour BioMed Partners With Lannacheng To Advance Next Generation Radionuclide Drug Conjugates

Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunolo...

January 02, 2026 | News

Aptamer Group Licenses Optimer Binder To Alphazyme For Hot Start PCR Applications

-Exclusive OEM license grants worldwide rights for Optimer® binder in molecular biology applications Royalty structure includes product sales, milesto...

December 31, 2025 | News

Intas Pharmaceuticals Limited Secures Exclusive Needle Free Injection Technology For IVF And Gynecology In India

Intas Pharmaceuticals Limited (“Intas”), a leading multinational pharmaceutical company, has entered into an exclusive agreement with ...

December 30, 2025 | News

EMA CHMP Backs Gotenfia Golimumab Biosimilar Advancing STADA and Bio Thera European Strategy

Positive opinion from European Medicines Agency supports approval for golimumab biosimilar Gotenfia® developed by Bio-Thera and to be marke...

December 30, 2025 | News

ABL Bio Lands Strategic 55 Million Funding Boost To Fast Track Next Wave Of Breakthrough Antibody Therapies

Secured a total of 55 million in R&D funding, including 40 million in upfront payment and 15 million in equity investment - Accelerating R&D on co...

December 29, 2025 | News

Niowave Extends Actinium 225 Supply Agreement With AstraZeneca To Support Next Generation Cancer Therapies

Niowave will expand its agreement to supply Actinium-225, a highly promising medical isotope, to AstraZeneca 10-year supply agreement ...

December 29, 2025 | News

China Approves First Dual Immunotherapy Neoadjuvant Regimen For MSI H dMMR Colon Cancer

TABOSUN® (ipilimumab N01 injection) has been approved in combination with TYVYT® (sintilimab injection) for the neoadjuvant treatment o...

December 26, 2025 | News

Bioeq And Zydus Secure USFDA Approval For Interchangeable Lucentis Biosimilar NUFYMCO

Bioeq AG ("Bioeq"), a Swiss biopharmaceutical company, and Zydus Lifesciences Limited ("Zydus"), an innovation-led life-sciences company with an internatio...

December 24, 2025 | News

GC Biopharma Secures MFDS Approval For Phase 1 Trial Of mRNA Covid 19 Vaccine Candidate

Phase 2 IND submission targeted for the second half of 2026- Demonstrating the competitiveness of GC Biopharma's mRNA platform GC Biopharma (...

December 24, 2025 | News

Stay Connected